CDISC launches COVID-19 research standards task force
The group will work to rapidly develop guidance on standardizing COVID-19 research data, with the help of several participating member companies.
The group will work to rapidly develop guidance on standardizing COVID-19 research data, with the help of several participating member companies.
The partnership will focus on generating novel small-molecule inhibitors against specific DUB targets for treatment of a range of diseases.
The agency continues to offer guidance about COVID-19 treatments and tests—and issue warnings to companies that fall out of line.